BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29083841)

  • 1. [NON-ALCOHOLIC FATTY LIVER DISEASE].
    Bukmir L; Smokrović H; Diminić-Lisica I; Ljubotina A; Popović B
    Acta Med Croatica; 2015 Nov; 69(4):305-10. PubMed ID: 29083841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S; Lulić D; Štimac D
    World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.
    Stefan N; Häring HU; Cusi K
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):313-324. PubMed ID: 30174213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease.
    Maurice J; Manousou P
    Clin Med (Lond); 2018 Jun; 18(3):245-250. PubMed ID: 29858436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis and treatment of non-alcoholic fatty liver disease.
    Altinbas A; Sowa JP; Hasenberg T; Canbay A
    Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic Fatty Liver Disease (NAFLD)--A Review.
    Karim MF; Al-Mahtab M; Rahman S; Debnath CR
    Mymensingh Med J; 2015 Oct; 24(4):873-80. PubMed ID: 26620035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists.
    Mann JP; Goonetilleke R; McKiernan P
    Arch Dis Child; 2015 Jul; 100(7):673-7. PubMed ID: 25633064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?
    Blond E; Disse E; Cuerq C; Drai J; Valette PJ; Laville M; Thivolet C; Simon C; Caussy C
    Diabetologia; 2017 Jul; 60(7):1218-1222. PubMed ID: 28352941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing non-alcoholic fatty liver disease.
    Ngu JH; Goh GB; Poh Z; Soetikno R
    Singapore Med J; 2016 Jul; 57(7):368-71. PubMed ID: 27439352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Buffet C
    Bull Acad Natl Med; 2014 Dec; 198(9):1641-52. PubMed ID: 27356366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease.
    Fisher CP; Kierzek AM; Plant NJ; Moore JB
    World J Gastroenterol; 2014 Nov; 20(41):15070-8. PubMed ID: 25386055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options.
    Milic S; Mikolasevic I; Krznaric-Zrnic I; Stanic M; Poropat G; Stimac D; Vlahovic-Palcevski V; Orlic L
    Drug Des Devel Ther; 2015; 9():4835-45. PubMed ID: 26316717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity.
    Kwak MS; Kim D
    Korean J Intern Med; 2018 Jan; 33(1):64-74. PubMed ID: 29202557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
    Williams T
    FP Essent; 2015 Aug; 435():24-9. PubMed ID: 26280342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
    Stavropoulos K; Imprialos K; Pittaras A; Faselis C; Narayan P; Kokkinos P
    Curr Vasc Pharmacol; 2018; 16(3):239-245. PubMed ID: 28637408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A global survey of health care workers' awareness of non-alcoholic fatty liver disease: The AwareNASH survey.
    Driessen S; de Jong VD; van Son KC; Klompenhouwer T; Colardelle Y; Alings M; Moreno C; Anker SD; Castro Cabezas M; Holleboom AG; Grobbee DE; Tushuizen ME
    United European Gastroenterol J; 2023 Sep; 11(7):654-662. PubMed ID: 37563849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.